JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CNTA
3651
DELISTED
Centessa Pharmaceuticals
CNTA
| $3.19M | ﹤0.01% |
190,385
+54,482
| +40% | +$903K |
2021 Q2
14 quarters
|
|
3652
PUT
3M
MMM
$83.5B
| $3.19M | ﹤0.01% |
24,700
| – | – |
2016 Q2
34 quarters
|
|
3653
Kura Oncology
KURA
$947M
| $3.19M | ﹤0.01% |
365,921
-43,320
| -11% | -$623K |
2017 Q3
29 quarters
|
|
3654
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.94B
| $3.19M | ﹤0.01% |
66,526
+8,088
| +14% | +$402K |
2022 Q4
8 quarters
|
|
3655
KNOT Offshore Partners
KNOP
$366M
| $3.18M | ﹤0.01% |
583,545
+141,213
| +32% | +$853K |
2023 Q3
5 quarters
|
|
3656
Invesco PHLX Semiconductor ETF
SOXQ
$3.42B
| $3.17M | ﹤0.01% |
80,921
+28
| +0% | +$1.12K |
2023 Q2
6 quarters
|
|
3657
Bloomin' Brands
BLMN
$726M
| $3.17M | ﹤0.01% |
259,278
-40,890
| -14% | -$586K |
2014 Q4
40 quarters
|
|
3658
PUT
Generac Holdings
GNRC
$12.8B
| $3.16M | ﹤0.01% |
20,400
| – | – |
2023 Q2
6 quarters
|
|
|
RPC
3659
Ridgepost Capital
RPC
$840M
| $3.16M | ﹤0.01% |
250,643
+232,938
| +1,316% | +$2.84M |
2023 Q2
6 quarters
|
|
3660
PUT
Vistra
VST
$47B
| $3.16M | ﹤0.01% |
22,900
-7,500
| -25% | -$1.04M |
2024 Q2
2 quarters
|
|
3661
Repay Holdings
RPAY
$317M
| $3.15M | ﹤0.01% |
413,364
-78,802
| -16% | -$630K |
2019 Q2
22 quarters
|
|
|
CALY
3662
Callaway Golf Company
CALY
$2.58B
| $3.15M | ﹤0.01% |
401,093
-17,350
| -4% | -$158K |
2014 Q4
40 quarters
|
|
3663
Bahl & Gaynor Small/Mid Cap Income Growth ETF
SMIG
$1.43B
| $3.15M | ﹤0.01% |
108,229
+105
| +0.1% | +$3.16K |
2023 Q4
4 quarters
|
|
3664
Perion Network
PERI
$334M
| $3.15M | ﹤0.01% |
371,518
-7,149
| -2% | -$60.1K |
2021 Q1
15 quarters
|
|
3665
GeoPark
GPRK
$704M
| $3.15M | ﹤0.01% |
339,337
+120,518
| +55% | +$1.07M |
2023 Q2
6 quarters
|
|
3666
Schwab Fundamental US Small Company Index ETF
FNDA
$8.75B
| $3.14M | ﹤0.01% |
105,849
+22,989
| +28% | +$702K |
2018 Q2
26 quarters
|
|
3667
AdvanSix
ASIX
$438M
| $3.14M | ﹤0.01% |
110,289
+5,705
| +5% | +$173K |
2016 Q4
32 quarters
|
|
3668
Alerian MLP ETF
AMLP
$12.8B
| $3.14M | ﹤0.01% |
65,240
+12,026
| +23% | +$578K |
2013 Q2
46 quarters
|
|
3669
PUT
Target Hospitality
TH
$1.84B
| $3.14M | ﹤0.01% |
325,000
| – | – |
2024 Q3
1 quarter
|
|
3670
Bioventus
BVS
$897M
| $3.14M | ﹤0.01% |
299,130
+45,390
| +18% | +$537K |
2021 Q1
15 quarters
|
|
|
NXH
3671
Neighborhood Intelligence Inc
NXH
$264M
| $3.14M | ﹤0.01% |
699,755
+271,092
| +63% | +$1.73M |
2017 Q4
28 quarters
|
|
|
ENFN
3672
DELISTED
Enfusion, Inc.
ENFN
| $3.12M | ﹤0.01% |
303,332
+95,310
| +46% | +$921K |
2021 Q4
12 quarters
|
|
3673
Invesco KBW Bank ETF
KBWB
$6.17B
| $3.11M | ﹤0.01% |
47,541
-1,006,078
| -95% | -$65.8M |
2017 Q2
30 quarters
|
|
3674
CALL
CMS Energy
CMS
$20B
| $3.11M | ﹤0.01% |
+46,600
| New | +$3.21M |
2024 Q4
0 quarters
|
|
3675
Methode Electronics
MEI
$561M
| $3.11M | ﹤0.01% |
263,381
+168,188
| +177% | +$1.83M |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.